Back

Dual V1a/V2 versus selective V2 vasopressin receptor blockade in a preclinical heart failure model: does it matter?

30 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Heart failure / Left ventricular dysfunction Pharmacologic therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Thomas Mondritzki

Bayer AG, Wuppertal (Germany)

49 More presentations in this session

Presentation thumbnail
Professor H. Duengen (Berlin, DE)
Presentation thumbnail
Doctor A. Ruwald (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Associate Professor N. Ermis (Malatya, TR)
Abstract Slides
Presentation thumbnail
Professor S. Nie (Beijing, CN)
Abstract Slides
Presentation thumbnail
Doctor K. Harada (Tokushima, JP)
Abstract

Access the full session

Session thumbnail
Poster session 7 - Heart failure / Left ventricular dysfunction

The Event

Event poster

ESC Congress 2016

30 August 2016 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources